We are live on ! Find out more
COCH icon

Envoy Medical
COCH

68 hedge funds and large institutions have $235M invested in Envoy Medical in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 3

300% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 3

19% more funds holding

Funds holding: 57 → 68 (+11)

11% more capital invested

Capital invested by funds: $212M → $235M (+$22.9M)

5.6% more ownership

Funds ownership: 51.39% → 56.99% (+5.6%)

Holders
68
Holders Change
+11
Holders Change %
+19.3%
% of All Funds
1.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
12
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PC
Periscope Capital
Ontario, Canada
+$8.7M
2
Citadel Advisors
Citadel Advisors
Florida
+$4.84M
3
Marshall Wace
Marshall Wace
United Kingdom
+$4.84M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$2.98M
5
GL
Governors Lane
New York
+$1.94M

Top Sellers

Rank Fund Capital Flow
1
AC
Antara Capital
New York
-$5.82M
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$248K
3
WA
Whitebox Advisors
Minnesota
-$46.5K
4
GCL
Glazer Capital LLC
New York
-$21K
5
Osaic Holdings
Osaic Holdings
Arizona
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
PMAM
26
Picton Mahoney Asset Management
Ontario, Canada
$2.91M – – –
DCM
27
Dupont Capital Management
Delaware
$2.91M – – –
CCA
28
Castle Creek Arbitrage
Colorado
$2.85M – – –
AC
29
Athanor Capital
New York
$2.71M – – –
MWNA
30
Marshall Wace North America
New York
$2.42M – – –
Bank of America
31
Bank of America
North Carolina
$2.21M – – –
Capstone Investment Advisors
32
Capstone Investment Advisors
New York
$1.94M – – –
MP
33
Mangrove Partners
Connecticut
$1.94M – – –
GL
34
Governors Lane
New York
$1.94M +$1.94M +200,000 New
GCM
35
Ghisallo Capital Management
Massachusetts
$1.82M – – –
MIM
36
Monashee Investment Management
Massachusetts
$1.46M – – –
TCM
37
Tenor Capital Management
New York
$1.46M – – –
CH
38
CVI Holdings
Delaware
$1.46M – – –
SCM
39
Segantii Capital Management
Hong Kong
$1.46M – – –
JP Morgan Chase
40
JP Morgan Chase
New York
$1.19M +$708K +73,116 +146%
Bank of Montreal
41
Bank of Montreal
Ontario, Canada
$1.17M -$248K -25,591 -18%
AC
42
Athos Capital
Hong Kong
$970K – – –
CC
43
Centiva Capital
New York
$970K – – –
MTIM
44
Marathon Trading Investment Management
Pennsylvania
$957K +$955K +98,665 New
CM
45
Cohanzick Management
New York
$843K +$841K +86,841 New
ASM
46
ATW SPAC Management
New York
$724K – – –
BFM
47
Boothbay Fund Management
New York
$724K – – –
KIM
48
Karpus Investment Management
New York
$713K – – –
AA
49
Ancora Advisors
Ohio
$696K – – –
OAC
50
OMERS Administration Corp
Ontario, Canada
$679K +$678K +69,999 New
1
2
3

COCH Hedge Fund Activity: Q3 2021 in Review

68 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q3 2021, worth a combined $235M — up 11% from $212M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new COCH positions and 3 closed out — a net gain of 11 holders — while 12 added to existing stakes and 3 trimmed.

The largest buyer was Periscope Capital, adding an estimated $8.7M. The largest seller was Antara Capital, exiting entirely with an estimated $5.82M sold.

  • 68 institutional investors held Envoy Medical (COCH) as of Q3 2021, up from 57 in Q2 2021.
  • Funds reported $235M of Envoy Medical stock for Q3 2021, up 11% quarter-over-quarter.
  • 14 funds opened new Envoy Medical positions in Q3 2021 and 3 closed out, a net change of +11 holders.
  • The largest Envoy Medical buyer in Q3 2021 was Periscope Capital, an estimated $8.7M added.
  • The largest Envoy Medical seller in Q3 2021 was Antara Capital, an estimated $5.82M sold.

Based on aggregated 13F filings for Q3 2021.